The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Open accessAbstract
Virtually every organism has evolved mechanisms by which, upon stimulation, lipids are released from plasma membranes and metabolized into mediators capable of changing cellular physiology. As these lipids are present at the first site exposed to external challenge, they provide an ideal substrate for the synthesis of defensive mediators and homeostatic regulators. One such group of lipid mediators is the prostanoids, including the prostaglandins (PGs) and thromboxanes (TXs). Soon after their initial isolation and characterization, the ability of prostanoids to influence inflammation and immune responses was recognized. For example, administration of prostanoids, either alone or in combination, could reproduce the cardinal signs of inflammation. Because they could induce inflammatory changes when injected into tissue and were present at high levels in inflamed lesions, prostanoids were initially categorized as proinflammatory mediators. As our understanding of prostanoid physiology has evolved, it has become clear that these mediators can act to both promote and inhibit inflammation. Thus, it is more accurate to envision these molecules as part of a complex regulatory network that modulates the actions of immune cells and the surrounding microenvironment. Their overall impact in an individual inflammatory response will depend on several factors, including the level of immune cell activation, the presence of other mediators, and the physiological state of the organism. Our ability to dissect the role of prostanoids in complex inflammatory responses has been substantially advanced by the recent development of mouse lines with targeted mutations of genes encoding enzymes and receptors in the prostanoid pathway. In this review we will develop the concept that prostanoids are both effectors and regulators of inflammation, emphasizing new information provided by these mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 969
Pène, J., Rousset, F., Brière, F., Chrétien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., & Banchereau, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6880 · Cited by 924
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773 · cited 3×
“Studies by Murata and colleagues showed that inflammatory pain responses are significantly reduced in mice lacking prostacyclin (IP) receptors, suggesting that IP receptors play a major role in the prostanoid-dependent component of pain (32).”
BackgroundInfluentialProstaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Prostaglandin Endoperoxide H Synthases-1 and -2
Smith, W. L., & Dewitt, D. L. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60430-7 · Cited by 711
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677 · cited 1×
“A number of lines of evidence suggest that the prostanoid responsible for fever production is PGE2, and studies using EPdeficient mice have shown that the febrile response to PGE2, IL-1β, and LPS occurs through the action of PGE2 on the EP3 receptor (39).”
BackgroundGenetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391
15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway
Straus, D. S. (2000) · Medical Entomology and Zoology · Cited by 371
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Self-citationWallace, J. L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K. A., & MacNaughton, W. K. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70370-1 · Cited by 336
Chouaib, S., Welte, K., Mertelsmann, R., & Dupont, B. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.1172 · Cited by 307
Morteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., & Sartor, R. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6899 · Cited by 275
Li, S., Wang, Y., Matsumura, K., Ballou, L. R., Morham, S. G., & Blatteis, C. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01225-1 · Cited by 270 · cited 1×
“Recent studies have shown that the febrile response to LPS is ameliorated in COX-2– but not COX-1–deficient mice, findings consistent with studies suggesting that COX-2 plays a dominant role in fever production (38).”
ResultMcAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
Self-citationThe prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure
Stock, J. L., Shinjo, K., Burkhardt, J., Roach, M., Taniguchi, K., Ishikawa, T., Kim, H.-S., Flannery, P. J., Coffman, T. M., McNeish, J. D., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci6749 · Cited by 235
Self-citationIn situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs
Oida, H., Namba, T., Sugimoto, Y., Ushikubi, F., Ohishi, H., Ichikawa, A., & Narumiya, S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15933.x · Cited by 230
Allergic lung responses are increased in prostaglandin H synthase–deficient mice
Gavett, S. H., Madison, S. L., Chulada, P. C., Scarborough, P. E., Qu, W., Boyle, J. E., Tiano, H. F., Lee, C. A., Langenbach, R., Roggli, V. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6890 · Cited by 196
Distribution and function of prostanoid receptors: studies from knockout mice
Sugimoto, Y., Narumiya, S., & Ichikawa, A. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00008-4 · Cited by 193
Nishigaki, N., Negishi, M., & Ichikawa, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09407-6 · Cited by 191
Naraba, H., Murakami, M., Matsumoto, H., Shimbara, S., Ueno, A., Kudo, I., & Oh-ishi, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2974 · Cited by 178
Reddy, S. T., & Herschman, H. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3231 · Cited by 171
LANGENBACH, R., LOFTIN, C. D., LEE, C., & TIANO, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08723.x · Cited by 170
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development
Rocca, B., Spain, L. M., Puré, E., Langenbach, R. J., Patrono, C., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6400 · Cited by 133
Ushikubi, F., Aiba, Y., Nakamura, K., Namba, T., Hirata, M., Mazda, O., Katsura, Y., & Narumiya, S. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1825 · Cited by 131
Raud, J., Dahlén, S., SYDBOM, A., Lindbom, L., & Hedqvist, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2315 · Cited by 125
Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin
M�ller-Decker, K., Reinerth, G., Krieg, P., Zimmermann, R., Heise, H., Bayerl, C., Marks, F., & F�rstenberger, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<648::aid-ijc6>3.0.co;2-d · Cited by 116
Identification of specific EP receptors responsible for the hemodynamic effects of PGE2
Audoly, L., Tilley, S. L., Goulet, J. L., Key, M. L., Nguyen, M., Stock, J. L., McNeish, J. D., Koller, B. H., & Coffman, T. M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h924 · Cited by 116
Self-citationPenglis, P. S., Cleland, L. G., Demasi, M., Caughey, G. E., & James, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1605 · Cited by 108
Goetzl, E. J., An, S. M., & Zeng, L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1041 · Cited by 84
Peebles, R. S., Dworski, R., Collins, R. D., Jarzecka, K., Mitchell, D. B., Graham, B. S., & Sheller, J. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9911063 · Cited by 79
Roper, R. L., Ludlow, J. W., & Phipps, R. P. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1079 · Cited by 47
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Research works printed but not linked: 10
- Nishigaki, 1996, Mol Pharmacol, 50, 1031
- 10.1084/jem.180.5.1967 · doi:10.1084/jem.180.5.1967
- Ruiz, 1992, Transplantation, 54, 498, 10.1097/00007890-199209000-00021 · doi:10.1097/00007890-199209000-00021
- Kaur, 1999, Adv Exp Med Biol, 469, 409, 10.1007/978-1-4615-4793-8_59 · doi:10.1007/978-1-4615-4793-8_59
- Khan, 1995, Adv Exp Med Biol, 383, 35, 10.1007/978-1-4615-1891-4_5 · doi:10.1007/978-1-4615-1891-4_5
- 10.1172/JCI200113455 · DOI
- Audoly, 1999, Am J Physiol, 277, H924
- Hitchcock, 1978, J Pharmacol Exp Ther, 207, 630
- 10.1021/bi00016a035 · doi:10.1021/bi00016a035
- 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9 · doi:10.1002/1529-0131(200012)43:12<2687::aid-anr8>3.0.co;2-9
Cited by
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Metadata
- Authors
- Tilley, S. L., Coffman, T. M., & Koller, B. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-07-01
- Volume
- 108
- Issue
- 1
- Pages
- 15-23
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2028089693
- Cited by
- 725
- References
- 44
- FWCI
- 24.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.